Also trades as: 94E.F (FSX) · $vol 0M
ZURA NASDAQ
Zura Bio Limited
1W: -2.5%
1M: +3.5%
3M: +2.4%
YTD: -0.2%
1Y: +237.8%
3Y: -18.9%
$5.54
+0.16 (+2.97%)
Weekly Expected Move ±15.6%
$4
$4
$5
$6
$7
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Bullish
75
Insider+$12.5M
Congress—
ETF Holdings—
Key Statistics
Market Cap$526.3M
52W Range1.345-7.44
Volume501,058
Avg Volume1,075,564
Beta-0.04
Dividend—
Analyst Ratings
Company Info
CEOSandeep C. Kulkarni
Employees40
SectorHealthcare
IndustryBiotechnology
IPO Date2023-03-21
Websitezurabio.com
1489 W. Warm Springs Road
Henderson, NV 89014
US
Henderson, NV 89014
US
858 247 0520
About Zura Bio Limited
Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and TSLP biological pathways. The company is also advancing Torudokimab, a monoclonal antibody that neutralizes IL-33, which is currently in Phase 2 clinical development.
Latest News
Zura Bio GAAP EPS of -$0.22
AST SpaceMobile, SBC Medical Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Boothbay Fund Management LLC Acquires New Shares in Zura Bio Limited $ZURA
Atika Capital Management LLC Takes Position in Zura Bio Limited $ZURA
12 Health Care Stocks Moving In Monday's After-Market Session
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Jarrett Jennifer | A-Award | 51,000 | $3.62 | 2026-06-17 |
| Thiara Parvinder | A-Award | 51,000 | $3.62 | 2026-06-17 |
| Schoch Steven J | A-Award | 51,000 | $3.62 | 2026-06-17 |
| Nirula Ajay | A-Award | 51,000 | $3.62 | 2026-06-17 |
| Munshi Amit | A-Award | 51,000 | $3.62 | 2026-06-17 |